The brugada syndrome

被引:33
|
作者
Brugada P. [1 ]
Brugada R. [2 ]
Brugada J. [3 ]
机构
[1] Cardiovascular Center, OLV Hospital, 9300 Aalst
[2] Baylor College of Medicine, Houston, TX
[3] Arrhythmia Unit, Hospital Clinic, University of Barcelona
关键词
Sudden Death; Sudden Cardiac Death; Antiarrhythmic Drug; Flecainide; Brugada Syndrome;
D O I
10.1007/s11886-000-0035-0
中图分类号
学科分类号
摘要
The Brugada syndrome is a hereditary disease causing sudden cardiac death in apparently healthy individuals with a structurally normal heart. The disease is caused by mutations in the cardiac sodium channel gene SCN5A. Patients with this disease have a peculiar electrocardiogram with elevation of the ST segment in leads V1 to V3, an electrocardiogram that every doctor should recognize. There exist variants of the electrocardiogram with minimal ST segment elevation and even concealed forms that can only be unmasked by the administration of class I antiarrhythmic drugs. When left untreated or when treated with all known antiarrhythmic drugs, patients with Brugada syndrome have a high mortality (approximately 10% per year). The only effective treatment to prevent sudden death is the implantable defibrillator. Copyright © 2000 by Current Science Inc.
引用
收藏
页码:507 / 514
页数:7
相关论文
共 50 条
  • [21] The definition of the Brugada syndrome
    Sieira, Juan
    Brugada, Pedro
    EUROPEAN HEART JOURNAL, 2017, 38 (40) : 3029 - 3034
  • [22] Brugada Syndrome: 30 Years of Scientific Adventure
    Brugada, Pedro
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (06): : 452 - 458
  • [23] Brugada syndrome in Thailand: Three decades of progress
    Veerakul, Gumpanart
    Khongphatthanayothin, Apichai
    Nademanee, Koonlawee
    HEART RHYTHM O2, 2022, 3 (06): : 743 - 751
  • [24] Flecainide test in Brugada syndrome: A reproducible but risky tool
    Gasparini, M
    Priori, SG
    Mantica, M
    Napolitano, C
    Galimberti, P
    Ceriotti, C
    Simonini, S
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (01): : 338 - 341
  • [25] Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation
    Brugada, Josep
    Pappone, Carlo
    Berruezo, Antonio
    Vicedomini, Gabriele
    Manguso, Francesco
    Ciconte, Giuseppe
    Giannelli, Luigi
    Santinelli, Vincenzo
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2015, 8 (06) : 1373 - 1381
  • [26] Anaesthesia in patients with Brugada syndrome
    Kim, JS
    Park, SY
    Min, SK
    Kim, JH
    Lee, SY
    Moon, BK
    Chae, YJ
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (08) : 1058 - 1061
  • [27] Genetic biomarkers in Brugada syndrome
    Li, Anthony
    Saba, Magdi M.
    Behr, Elijah R.
    BIOMARKERS IN MEDICINE, 2013, 7 (04) : 535 - 546
  • [28] The Brugada syndrome: Facts and controversies
    Boussy, Tim
    Sarkozy, Andrea
    Chierchia, Gian-Battista
    Richter, Sergio
    Brugada, Pedro
    HERZ, 2007, 32 (03) : 192 - 200
  • [29] Delayed depolarization and histologic abnormalities underlie the Brugada syndrome
    Martini, Bortolo
    Martini, Nicolo
    De Mattia, Luca
    Buja, Gianfranco
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (02): : 172 - 181
  • [30] Brugada syndrome and syncope: a practical approach for diagnosis and treatment
    Mascia, Giuseppe
    Della Bona, Roberta
    Ameri, Pietro
    Canepa, Marco
    Porto, Italo
    Parati, Gianfranco
    Crotti, Lia
    Brignole, Michele
    EUROPACE, 2021, 23 (07): : 996 - 1002